Search research articles
Contact Us
Filters
Showing results (611-620 of 899) with videos related to
Page
of 90
Sort By:
Toxicology and Applied Pharmacology
|
March 1, 1993
The effect of 1-chloro-2,4-dinitrobenzene exposure on antigen receptor (CD3)-stimulated transmembrane signal transduction in purified subsets of human peripheral blood lymphocytes
T J Kavanagh, A Grossmann, J C Jinneman, et al.
Nature
|
December 3, 1992
Cloning and expression of a rat brain L-glutamate transporter
G Pines, N C Danbolt, M Bjørås, et al.
Restorative Neurology and Neuroscience
|
October 8, 2003
Peripheral markers of brain damage and blood-brain barrier dysfunction
Nicola Marchi, Peter Rasmussen, Miranda Kapural, et al.
Clinical Neurology and Neurosurgery
|
June 26, 2012
Temporal lobe gangliogliomas associated with chronic epilepsy: long-term surgical outcomes
David Wallace, Dmitry Ruban, Andres Kanner, et al.
Clinical Genetics
|
January 22, 2024
Clinical phenotypic spectrum of CTNNB1 neurodevelopmental disorder
Khemika K Sudnawa, Alison Garber, Ryan Cohen, et al.
Journal of Neuro-Oncology
|
May 6, 2015
Calcification in high grade gliomas treated with bevacizumab
Deborah T Blumenthal, Orna Aisenstein, Idan Ben-Horin, et al.
Journal of Neuro-Oncology
|
March 12, 2025
Long-term impact of bevacizumab for the treatment of brain radiation necrosis
Hila Nobel, Jonathan Ofer, Sara Faye Borenstein, et al.
Frontiers in Immunology
|
February 17, 2025
Case report: JAK inhibitor treatment of immune dysregulation symptoms in a patient with PTPN2 deficiency
Anna Roppelt, Ulyana Markina, Irina Beloglazova, et al.
Neuro-Oncology Advances
|
October 21, 2024
A phase II, open-label, single-arm trial of pembrolizumab for recurrent meningioma and solitary fibrous tumor
Dror Limon, Alexandra Amiel, Shaked Even Haim, et al.
Journal of Neurosurgery
|
November 26, 2014
Conflicting pathology reports: a diagnostic dilemma
Tal Shahar, Uri Rozovski, Yuval Shapira, et al.
Page
of 90
Search research articles
Search
Showing results (611-620 of 899) with videos related to
Sort By:
Page
of 90
Toxicology and Applied Pharmacology
|
March 1, 1993
The effect of 1-chloro-2,4-dinitrobenzene exposure on antigen receptor (CD3)-stimulated transmembrane signal transduction in purified subsets of human peripheral blood lymphocytes
T J Kavanagh, A Grossmann, J C Jinneman, et al.
Nature
|
December 3, 1992
Cloning and expression of a rat brain L-glutamate transporter
G Pines, N C Danbolt, M Bjørås, et al.
Restorative Neurology and Neuroscience
|
October 8, 2003
Peripheral markers of brain damage and blood-brain barrier dysfunction
Nicola Marchi, Peter Rasmussen, Miranda Kapural, et al.
Clinical Neurology and Neurosurgery
|
June 26, 2012
Temporal lobe gangliogliomas associated with chronic epilepsy: long-term surgical outcomes
David Wallace, Dmitry Ruban, Andres Kanner, et al.
Clinical Genetics
|
January 22, 2024
Clinical phenotypic spectrum of CTNNB1 neurodevelopmental disorder
Khemika K Sudnawa, Alison Garber, Ryan Cohen, et al.
Journal of Neuro-Oncology
|
May 6, 2015
Calcification in high grade gliomas treated with bevacizumab
Deborah T Blumenthal, Orna Aisenstein, Idan Ben-Horin, et al.
Journal of Neuro-Oncology
|
March 12, 2025
Long-term impact of bevacizumab for the treatment of brain radiation necrosis
Hila Nobel, Jonathan Ofer, Sara Faye Borenstein, et al.
Frontiers in Immunology
|
February 17, 2025
Case report: JAK inhibitor treatment of immune dysregulation symptoms in a patient with PTPN2 deficiency
Anna Roppelt, Ulyana Markina, Irina Beloglazova, et al.
Neuro-Oncology Advances
|
October 21, 2024
A phase II, open-label, single-arm trial of pembrolizumab for recurrent meningioma and solitary fibrous tumor
Dror Limon, Alexandra Amiel, Shaked Even Haim, et al.
Journal of Neurosurgery
|
November 26, 2014
Conflicting pathology reports: a diagnostic dilemma
Tal Shahar, Uri Rozovski, Yuval Shapira, et al.
Page
of 90